2012-05-15
DSM Biomedical: A case study for developing a new business
CMS Pharma's Andrew Badrot explores DSM's growth strategy and their ability to successfully see through the methodical build-up of new business fields. He uses DSM's latest acquisition in the biomedical space (Kensey Nash) to illustrate some of his arguments.
Read Article
- -
2012-02-08
Contract Pharma: A $500 Million Blunder?
CMS Pharma's Andrew Badrot comments on the hasty dismissal of Lonza's CEO and the ensuing negative impact on shareholder value.
Read Article
- -
2012-01-23
Contract Pharma: API Manufacturing - Facts and Fiction
CMS Pharma's Andrew Badrot writes in collaboration with Peter Pollak and Rolf Dach a seminal article on the cost of API manufacturing. The data-rich article analyzes the competitiveness of various geographies, outlines future cost developments and tackles some misconceptions around API outsourcing.
Read PDF
- -
2011-11-04
Contract Pharma: The China Challenge
CMS Pharma's Andrew Badrot writes about how to balance short-term profits and long-term competitive advantage while doing business in China and major obstacles Western companies face.
Read PDF
- -
2011-10-26
CMS Pharma Hosts the M&A Workshop at the CPhI Worldwide Lunchtime Education Series in Frankfurt on October 26, 2011 at 14:00
The M&A lunchtime workshop explores the fundamental drivers behind M&A transactions and focuses on the pharmaceutical industry. It examines typical pharma valuation benchmarks. It evaluates the redesign of the pharmaceutical industry in the past years and conclude with a future outlook for Pharma M&A. The case studies explore various facets of the Pharma value chain, covering one mega-merger transaction (Sanofi - Genzyme), one CMO transaction (Lonza - Arch Chemicals) and one CRO transaction (Covance - Sanofi).
Read PDF
- -
2011-10-24
CMS Pharma Chairs the Inaugural CPhI Contract Partnership Executive Summit in Frankfurt on October 24, 2011
This new Series of Executive Conferences by CPhI is designed in conjunction with CMS Pharma. The CPhI Contract Partnership Executive Summit is a unique, content-driven event that provides the contract manufacturing, research and formulation sectors with the opportunity to discuss and debate the future direction of the industry, successful business strategies and where the opportunities for growth lie.
www.cphi.com
Read PDF
- -
2011-10-05
Contract Pharma Expert Opinion: Why BI's Biosimilar Announcement Just Makes Sense
CMS Pharma's Andrew Badrot publishes an expert opinion explaining why Boehringer Ingelheim is primed for success in the burgeoning biosimilar market.
www.contractpharma.com
- -
2011-09-19
Contract Pharma Expert Opinion: When The Unexpected Happens
CMS Pharma's Andrew Badrot publishes an expert opinion on the state of the CMO industry, past, present and future. He pays tribute to the lasting impact of Peter Pollak on the industry.
www.contractpharma.com
- -
2011-06-01
Contract Pharma Expert Opinion: China Vs. India in the API Race?
CMS Pharma's Andrew Badrot publishes an expert opinion on the controversial topic of China vs. India in API exports and goes on record.
www.contractpharma.com
- -
2011-05-24/25
CPhI Strategies in Pharma Outsourcing 2011 Conference, Berlin, Germany
CMS Pharma chairs the two-day conference and delivers the keynote speech around the future of the CMO and CRO industry
www.outsourcing-pharma.org
- -
2011-04-27/28
Nextgen 2011: Super-Generics Strategies India, Mumbai, India
CMS Pharma chairs the panel discussion "Global perspectives on partnership opportunities with Indian generic manufacturers – leveraging the India advantage"
www.nextgen-in.com
- -
2011-02-21
Chemical & Engineering News Journal
CMS Pharma's Andrew Badrot is quoted in Rick Mullin's article on the Sanofi-Genzyme takeover entitled "Sanofi, Genzyme come to terms"
Read PDF
- -
2011-02-08
Informex 2011: Pharma Manufacturing Strategy Think Tank, Charlotte, NC, USA
CMS Pharma hosts a Strategy Think Tank conference session addressing the fundamental shifts in pharma custom manufacturing. The session includes a 45min presentation by Andrew Badrot followed by a panel discussion chaired by Dr. Peter Pollak.
Read PDF
- -
2010-04-26/27
CPhI Pharma Outsource 2010 Conference, Berlin, Germany
CMS Pharma speaks about the risks associated with manufacturing site takeovers, outlines the future pharma manufacturing landscape and the role of CMOs as key partners for pharmaceutical companies.
Read PDF
- -
2010-04-19
ICIS Chemical Business
Andrew Badrot reacts to a seminal article written by Clay Boswell "A nice piece of real estate", suggesting Big Pharma should shut down their manufacturing sites rather than sell them to CMOs.
Read PDF